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Heme oxygenase-1 (HO-1) is an anti-oxidant enzyme
normally upregulated in response to oxidant injury. Here we
determined the role of HO-1 in podocyte apoptosis in
glomeruli of streptozotocin-treated rats and in immortalized
mouse podocytes cultured in media containing normal or
high glucose. HO-1 expression, its activity, the ratio of
Bax/Bcl-2 protein, and active caspase-3 fragments were all
significantly higher in isolated glomeruli of diabetic rats
and in high glucose–treated podocytes. These increases were
inhibited by zinc protoporphyrin treatment of the rats or
by HO-1 siRNA treatment of the podocytes in culture. The
number of apoptotic cells was also significantly increased
in the glomeruli of diabetic rats and in high glucose–treated
podocytes. Inhibition of HO-1 accentuated the increase in
apoptotic cells both in vivo and in vitro. Our findings suggest
that HO-1 expression protects against podocyte apoptosis
under diabetic conditions.
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Heme oxygenase (HO) is a microsomal rate-limiting enzyme
involved in the degradation of heme to biliverdin, which is
rapidly converted into bilirubin by biliverdin reductase.1,2
During this step, iron is released from the heme ring and
carbon monoxide is generated.1 To date, three distinct
isoforms of HO have been identified: HO-1, an inducible
form; HO-2, a constitutive form; and HO-3, probably a
pseudogene.3–5 Among these isoforms, HO-1 has been the
most extensively studied HO isoenzyme and is known to be
upregulated in the kidney under various conditions char-
acterized by oxidative stress, including toxic nephropathy,6,7
ischemia–reperfusion injury,8,9 contrast nephropathy,10 and
acute transplant rejection.11 Oxidants generating molecules
such as angiotensin II,12,13 heme,14 proinflammatory cyto-
kine,15 and transforming growth factor-b116 are also reported
to induce HO-1. In addition, pharmacological inhibition of
HO activity or deletion of the HO-1 gene worsened renal
injury induced by toxic substances and ischemia–reperfu-
sion,7,17–19 whereas earlier induction of HO-1 protected
against renal injury.18,20–23 On the basis of these findings,
HO-1 is thought to function as an antioxidant, which is
upregulated to alleviate the deleterious consequences of
oxidant injury.
The number of podocytes is decreased in the glomeruli of
diabetic patients and animal models of diabetes (DM),24–26
and apoptosis is known to be involved in podocyte loss under
DM conditions.26,27 Previous studies have demonstrated that
high glucose (HG) per se and transforming growth factor-b1,
two major mediators in the development and progression of
DM nephropathy, increase reactive oxygen species production
and induce apoptosis in cultured podocytes.26,28,29 Moreover,
podocyte apoptosis under these conditions is prevented by the
administration of antioxidants, suggesting that oxidative stress
with increased reactive oxygen species is responsible for
apoptosis of podocytes under DM conditions.26,30
On the basis of these findings, an increase in HO-1
expression has been expected and been demonstrated in
experimental DM glomeruli, mainly in mesangial cells and
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podocytes,31,32 but the functional significance of this increase
has not yet been explored. In this study, we investigated the
expression of HO-1 as well as podocyte apoptosis in
experimental DM glomeruli and in HG-stimulated cells
before and after inhibiting HO activity to elucidate the role of
HO-1 in podocyte apoptosis under DM conditions.
RESULTS
Animal studies
Animal data. Body weight and the ratio of kidney weight
to body weight were significantly different between DM
(275±8 g, 1.12±0.11%) and control (C) rats (398±8 g,
0.69±0.04%) (Po0.05). However, the administration of zinc
protoporphyrin (ZnPP) had no effect on either body weight
or the ratio of kidney weight to body weight in C and DM
rats. The mean blood glucose levels of C, CþZnPP, DM, and
DMþZnPP were 97.2±7.7, 94.1±5.4, 497.2±14.8, and
488.7±17.2mg per 100ml, respectively (Po0.01). Com-
pared with the C group (0.32±0.04mg/day), 24-h urinary
albumin excretion was significantly higher in the DM group
(1.18±0.11mg/day, Po0.05), and was further increased in
DM rats by ZnPP treatment (1.59±0.19mg/day, Po0.05)
(Table 1). The administration of ZnPP also significantly
aggravated the increase in 24-h urine albumin excretion in
female DM rats (1.37±0.15 vs 0.85±0.11mg/day, Po0.05),
suggesting that the effect of ZnPP was not gender-specific.
In contrast, the blood urea nitrogen and serum creatinine
levels and systolic blood pressure were comparable among
the four groups (Table 1).
Localization of glomerular HO-1 protein. Double immuno-
fluorescence staining for HO-1 and synaptopodin revealed
that podocytes were the main cells responsible for the
increase in HO-1 protein under DM conditions (Figure 1).
Glomerular HO-1 and HIF-1 protein expression. Glomerular
HO-1 protein expression assessed by western blot was
significantly higher in DM compared with C rats (Po0.05),
whereas ZnPP treatment significantly inhibited the increase
in HO-1 protein expression in DM rats (Po0.05) (Figure 2).
In contrast, ZnPP had little effect on glomerular HO-1
protein expression in C rats. To explore the possible
mechanism how ZnPP inhibited HO-1 protein expression,
we investigated the effect of ZnPP treatment on the
expression of hypoxia-inducible factor-1 (HIF-1). As HO-1
is a downstream factor of HIF-1, we assumed that ZnPP
Table 1 | Animal data
Control (n=8) Control+ZnPP (n=8) DM (N=8) DM+ZnPP (n=8)
Body weight (g) 398±8 405±7 275±8* 266±2*
Kidney weight/body weight (%) 0.69±0.04 0.75±0.05 1.12±0.11* 1.20±0.09*
Blood glucose (mg per 100ml) 97.2±7.7 94.1±5.4 497.2±14.8# 488.7±17.2#
24-h UAE (mg/day) 0.32±0.04 0.29±0.08 1.18±0.11* 1.59±0.19#,w
BUN (mg per 100ml) 19.8±1.3 20.3±2.1 23.9±2.9 24.2±3.3
Serum creatinine (mg per 100ml) 0.83±0.05 0.80±0.07 0.85±0.10 0.87±0.13
Systolic blood pressure (mmHg) 111.1±9.8 112.5±8.5 115.3±11.8 116.7±10.5
BUN, blood urea nitrogen; DM, diabetes; UAE, urinary albumin excretion; ZnPP, zinc protoporphyrin.
*Po0.05 vs control group, #Po0.01 vs control group, wPo0.05 vs DM group.
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Figure 1 |Double immunofluorescence staining for heme oxygenase (HO)-1 (red) and synaptopodin (green) in control (C) and diabetic
(DM) rats. Compared with C, immunofluorescence staining for HO-1 was increased in DM glomeruli, and double immunofluorescence
staining revealed that the increase in HO-1 protein expression was mainly attributed to its increase in podocytes. (400).
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may inhibit HIF-1 expression, leading to the decrease in
HO-1 expression. Western blot for HIF-1 revealed that
the increase in glomerular HIF-1 protein expression
in DM rats was significantly abrogated by ZnPP treatment
(Po0.05) (Figure 2a).
In the experiments using DM rats treated with insulin, the
increases in HO-1 and HIF-1 expression in 6-week DM
glomeruli were significantly ameliorated by insulin treatment
(Po0.05), suggesting that these changes in STZ-induced DM
rats were not because of STZ per se (Figure 2b).
Immunohistochemical staining for glomerular HO-1
confirmed the western blot findings, as glomerular HO-1
staining was significantly stronger in DM than in C rats, and
ZnPP treatment attenuated the increase in HO-1 staining in
DM glomeruli (Figure 3). The mean semiquantitative
staining score for glomerular HO-1 was significantly higher
in DM (75.7±9.0) compared with C rats (22.4±2.4)
(Po0.01), and this increase was inhibited in DM glomeruli
by the administration of ZnPP (37.8±5.4) (Po0.05).
Glomerular HO activity. In addition to HO-1 protein
expression, HO activity was also significantly increased in
DM compared with C glomeruli (Po0.01), and ZnPP
treatment significantly abrogated the increase in glomerular
HO activity in DM rats (Po0.05) (Figure 4).
Bax, Bcl-2, and active fragments of caspase-3 protein
expression. Bax and active fragments of caspase-3 protein
expression were significantly increased, whereas Bcl-2 protein
expression was significantly decreased in DM compared
with C glomeruli (Po0.05). The administration of ZnPP
significantly aggravated the increases in the ratios of
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Figure 2 |Western blot analysis of glomerular heme oxygenase (HO)-1 and hypoxia-inducible factor-1 (HIF-1) protein expression.
(a) A representative western blot of HO-1 and HIF-1 in control (C), Cþ ZnPP, diabetic (DM), and DMþ ZnPP rats (representative of four
blots). HO-1 and HIF-1 protein expression was 2.4- and 2.1-fold higher in DM compared with C glomeruli, respectively, and these increases
were significantly ameliorated in DM rats by ZnPP treatment. (b) A representative western blot of glomerular HO-1 and HIF-1 in C, DM, and
DMþ insulin (I) rats (representative of four blots). The increases in HO-1 and HIF-1 expression in 6-week DM glomeruli were significantly
attenuated by insulin treatment, suggesting that these changes in STZ-induced DM rats were not due to STZ per se. *Po0.05 vs C and
Cþ ZnPP groups, #Po0.05 vs DM group. STZ, streptozotocin; ZnPP, zinc protoporphyrin.
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Bax/Bcl-2 (Po0.01) and active fragments of caspase-3
protein expression in DM glomeruli (Po0.05) (Figure 5).
TUNEL assay and double immunofluorescence staining. In
addition to Bax, Bcl-2, and active fragments of caspase-3
protein expression, apoptosis in glomeruli was assessed by
terminal deoxynucleotidyl transferase-mediated deoxyuridine
triphosphate (dUTP) nick end labeling (TUNEL) assay. The
number of glomerular apoptotic cells was significantly
increased in DM compared with C and CþZnPP rats
(Po0.01), and was further increased in DM rats by ZnPP
treatment (Po0.05) (Figure 6a). To identify podocyte
apoptosis in glomeruli, double immunofluorescence staining
with antibodies to synaptopodin, a podocyte marker, and
active fragments of caspase-3 was performed. As seen in
Figure 6b and c, CþZnPP rats showed a faint staining of
active fragments of caspase-3 with little colocalization with
synaptopodin, while the colocalization signal was increased
in DM glomeruli and was highest in the glomeruli of
DMþZnPP rats.
Podocyte numbers. Compared with C (170.0±4.2) and
CþZnPP rats (168.3±5.9), the number of podocyte tended
to be decreased in DM rats (159.1±3.7), and the reduction
in podocyte numbers was aggravated in DM rats treated with
ZnPP (142.9±3.2) (Po0.05).
Cultured podocytes studies
HO-1 and HIF-1 protein expression. Western blot analysis
revealed that HO-1 small interfering RNA (siRNA) inhibited
HO-1 protein expression in a dose-dependent manner
(Figure 7). In contrast, HG significantly increased HO-1
and HIF-1 protein expression in cultured podocytes by 131
and 103%, respectively, compared with normal glucose (NG)
cells (Po0.05), and the increase in HO-1 expression in HG-
stimulated podocytes was significantly ameliorated by HO-1
siRNA treatment (Figure 8a).
Podocyte HO activity. In addition to HO-1 protein
expression, HO activity was also significantly increased in
HG-stimulated podocytes compared with podocytes exposed
to NG medium (4.4±0.6 vs 21.8±3.1 pmol bilirubin per mg
protein per h, Po0.01), and HO-1 siRNA treatment
significantly attenuated the increase in HO activity in HG
cells (3.1±0.5 pmol of bilirubin per mg protein per h)
(Po0.005).
Bax, Bcl-2, and active fragments of caspase-3 expression. The
ratios of Bax/Bcl-2 and active fragments of caspase-3 protein
expression were significantly increased in HG-stimulated
podocytes compared with podocytes exposed to NG and
NGþM media (Po0.05), and these increases were
accentuated in HG cells by HO-1 siRNA (Po0.05). In
contrast, there were no changes in Bax/Bcl-2 protein ratios
and active fragments of caspase-3 protein expression in HO-1
siRNA-treated NG cells (Figure 8b).
HO-1, Bax, Bcl-2, and active fragments of caspase-3 expression
in hemin-pretreated podocytes. Hemin pretreatment signifi-
cantly induced HO-1 protein expression in cultured
podocytes exposed to NG and HG media (Po0.005). In
addition, HO-1 induction by hemin before HG stimulation
significantly attenuated the increases in Bax/Bcl-2 ratios and
active fragment of caspase-3 protein expression in HG-
stimulated podocytes (Po0.05) (Figure 9).
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Figure 3 | Immunohistochemical staining for heme oxygenase
(HO)-1 in control (C), CþZnPP, diabetic (DM), and DMþZnPP
rats. Glomerular HO-1 staining (arrowheads) was significantly
stronger in DM compared with C and Cþ ZnPP rats, and this
increase was inhibited in DM glomeruli by the administration of
ZnPP. (400). *Po0.01 vs C and Cþ ZnPP groups, #Po0.05 vs DM
group. ZnPP, zinc protoporphyrin.
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Figure 4 |Glomerular heme oxygenase (HO) activity (pmol
bilirubin/mg protein per h) in control (C), CþZnPP, diabetic
(DM), and DMþZnPP rats. HO activity was significantly
increased in DM compared with C glomeruli, and ZnPP treatment
significantly abrogated the increase in glomerular HO activity in
DM rats. *Po0.01 vs C and Cþ ZnPP groups, #Po0.05 vs DM
group. ZnPP, zinc protoporphyrin.
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Hoechst 33342 staining. Apoptotic cells assessed by Hoechst
33342 staining were significantly increased in HG-stimulated
podocytes compared with NG cells (Po0.05), and apoptosis in
HG podocytes was further increased by HO-1 siRNA (Po0.05).
In contrast, hemin pretreatment significantly protected HG
podocytes against apoptosis (Po0.05) (Figure 10).
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Figure 5 |A representative western blot of Bax, Bcl-2, and active fragments of caspase-3 protein expression in control (C), CþZnPP,
diabetic (DM), and DMþZnPP glomeruli (representative of four blots). The ratios of Bax/Bcl-2 and active fragments of caspase-3
protein expression were significantly increased in DM compared with C glomeruli, and the administration of ZnPP significantly aggravated these
increases in DM glomeruli. *Po0.05 vs C and Cþ ZnPP groups, #Po0.01 vs DM group, wPo0.05 vs DM group. ZnPP, zinc protoporphyrin.
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Figure 6 |Assessment of apoptosis in glomeruli. (a) Apoptosis assessed by TUNEL assay in control (C), Cþ ZnPP, diabetic (DM), and
DMþ ZnPP rats. There was a significant increase in apoptotic cells (arrow heads) in DM compared with C and Cþ ZnPP glomeruli, and this
increase in apoptotic cells was accentuated with ZnPP treatment. (b) Double immunofluorescence staining for active fragments of caspase-
3 (red) and synaptopodin (SP) (green). Compared with C and Cþ ZnPP rats, the colocalization signal (yellow) was increased in DM glomeruli,
and was highest in the glomeruli of DMþ ZnPP rats. (400). *Po0.01 vs C and Cþ ZnPP groups, #Po0.05 vs DM group. ZnPP, zinc
protoporphyrin.
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DISCUSSION
Earlier studies have demonstrated that HO-1 has a protective
role in various kidney diseases in which oxidative stress is
thought to have a role.6–11 However, the functional
significance of HO-1 in terms of podocyte apoptosis in
DM nephropathy has not been elucidated. In this study, we
demonstrate that HO-1 expression is increased in experi-
mental DM glomeruli and in HG-stimulated podocytes. In
addition, to our knowledge, this is the first study showing
that podocyte apoptosis under DM conditions is partly
protected by this increase in HO-1 expression.
Heme oxygenase is an enzyme that cleaves the heme ring,
thereby converting heme into biliverdin and releasing iron
and carbon monoxide.1,2 By this process, HO regulates the
cellular levels of heme, which is known to act as a pro-
oxidant and to induce cell dysfunction. Therefore, when
cellular heme levels are increased by denaturation or
destabilization of heme protein during cell injury, HO
increases to remove heme and replace it with bilirubin, a
potent antioxidant.1,2 The cytoprotective role of HO was first
suggested by Keyse and Tyrrell33 who identified HO as a
sodium arsenite-induced 32-kDa protein in cultured human
skin fibroblasts and found that the HO gene is also induced
by ultraviolet A radiation, hydrogen peroxide, and heavy
metal salts. On the basis of these findings, they suggested that
the induction of HO may be a general response to oxidant
stress and that HO constitutes an important cellular defense
mechanism against oxidative damage. Following this report,
numerous studies have investigated the expression and the
functional role of HO, especially of HO-1, the isoform of HO
induced under stressed conditions. In the kidney, HO-1
is weakly expressed in proximal and distal tubules, in
Henle’s loop, and in medullary collecting ducts under normal
state, but its expression is increased under various condi-
tions.1 The functional role of increased HO-1 expression has
been elucidated in toxic nephropathy and in renal ische-
mia–reperfusion injury,7,17–19,23,34–36 in which oxidative stress
has a role in the pathogenesis. Upregulation of HO-1 reduced
renal injury induced by cyclosporine23 and potassium
dichromate,34 and protected tubular cell injury induced by
cisplatin,18 whereas inhibition of HO-1 expression exacer-
bated renal injury in maleate nephropathy19 and worsened
cisplatin-induced cell injury.7 In addition, induction of HO-1
by hemolysate,35 tin chloride,21 or cobalt36 ameliorated
ischemic acute renal injury in rats, whereas mild renal
ischemia exerted severe renal dysfunction and increased
mortality in HO-1 knockout mice compared with control
mice.37 Taken together, HO-1 seems to be induced to protect
cells against oxidative stress-induced renal injury.
On the basis of these earlier reports, HO-1 expression was
surmized to be increased in DM nephropathy in response to
oxidative stress. Recently, Hayashi et al.31 and Koya et al.32
demonstrated that HO-1 mRNA and protein expression were
induced in DM glomeruli and antioxidant treatment nearly
normalized the increase in HO-1 expression, suggesting that
glomerular HO-1 expression was increased secondary to
DM-induced oxidative stress. The former investigators also
showed that the glomerular cells with increased HO-1
protein expression were mesangial cells and podocytes.
However, these two studies did not examine the biological
significance of increased glomerular HO-1 expression under
DM conditions. This study also demonstrates that HO-1
expression is increased not only in experimental DM
glomeruli but also in HG-stimulated podocytes, which is in
accordance with the earlier studies.31,32
The cytoprotective effect of HO-1 seems to be attributed
to the antiapoptotic role of the HO system. Shiraishi et al.18
showed that renal failure and renal injury characterized by
tubular apoptosis were more severe in transgenic mice
deficient in HO-1 compared with wild-type mice treated
with cisplatin. Cisplatin-induced apoptosis in cultured
proximal tubular epithelial cells was significantly attenuated
by inducing HO-1 expression, whereas inhibition of HO-1
enzyme activity reversed the antiapoptotic effect. On the
basis of these findings, the researchers postulated that HO-1
had a cytoprotective effect by preventing apoptosis induced
by oxidative stimuli. The antiapoptotic effect of HO-1 seems
to be mediated by upregulating the expression of p21, an
antiapoptotic cell-cycle protein, in renal tubular epithelial
cells.38 In some cells, carbon monoxide, a metabolite of the
HO system, is responsible for the antiapoptotic effect of
HO-1,39,40 while augmentation of iron efflux by HO-1
contributes to its antiapoptotic property in cultured
fibroblasts.41 This study demonstrates for the first time that
apoptosis in experimental DM glomeruli and in
HG-stimulated podocytes is further accentuated in an
HO-1-suppressed state both in vivo and in vitro, suggesting
that podocyte HO-1 expression is induced to protect against
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Figure 7 |A representative western blot of heme oxygenase
(HO)-1 in cultured podocytes treated with three different
concentrations of HO-1 small interfering RNA (siRNA)
(representative of four blots). HO-1 siRNA inhibited HO-1
protein expression in a dose-dependent manner. *Po0.05 vs NG
group, #Po0.01 vs NG group. NG, normal glucose.
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podocyte apoptosis under DM conditions. In addition,
double immunofluorescence staining with active fragments
of caspase-3 and synaptopodin in ZnPP-treated DM rats
revealed that podocytes were the glomerular cells with
augmented apoptosis. On the basis of these findings, the
further increase in albuminuria in DM rats treated with
ZnPP may be attributed to exacerbated apoptosis of
podocytes under an HO-1-inhibited state.
To clarify the functional role of HO-1 in DM nephropathy,
ZnPP and HO-1 siRNA were used in this study to inhibit
HO-1 in vivo and in vitro, respectively, and hemin to induce
HO-1 in vtiro. Accumulating evidence have shown that
both HO-1 expression and activity were inhibited by ZnPP
treatment.12,42,43 Moreover, earlier studies have shown that
HIF-1 is an upstream factor of HO-1 and that the
administration of ZnPP inhibited the mRNA expression
and activity of HIF-1, leading to a decrease in HO-1
expression.44 In this study, we demonstrated that the
expression of HIF-1 was increased in DM glomeruli and in
HG-stimulated podocytes and these increases were abrogated
by ZnPP treatment, suggesting that the inhibitory effect of
ZnPP on HO-1 expression under DM conditions was
attributed to its effect on HIF-1 expression.
Although the majority of earlier in vivo studies used ZnPP
to suppress HO activity, ZnPP is known to inhibit not only
HO-1 but also HO-2.45 For this reason, the results of this
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Figure 8 |A representative western blot of heme oxygenase (HO)-1, hypoxia-inducible factor-1 (HIF-1), and apoptosis-related
molecules in cultured podocytes (representative of four blots). (a) There were significant increases in HO-1 and HIF-1 expression in
HG-stimulated podocytes compared with NG and NGþM cells, and the increase in HO-1 protein expression in HG podocytes was
significantly ameliorated by HO-1 siRNA treatment (20nmol). (b) The ratios of Bax/Bcl-2 and active fragments of caspase-3 protein expression were
significantly increased in HG-stimulated podocytes compared with normal glucose (NG) and NGþM groups, and these increases were accentuated
in high glucose (HG) cells by HO-1 siRNA (20nmol). *Po0.05 vs NG and NGþM groups, #Po0.01 vs HG group, wPo0.05 vs DM group. HG, high
glucose; Ng, normal glucose; NG+M, normal glucose plus mannitol.
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in vivo study could not definitively determine whether the
increase in podocyte apoptosis was due to the blockade of
HO-1 and/or HO-2 activity. For the current in vitro
experiments, HO-1 siRNA was therefore introduced to
selectively inhibit HO-1, which led to an increase in
apoptosis of podocytes under DM conditions, consistent
with the animal study. In contrast, we also demonstrated that
HO-1 induction by hemin pretreatment significantly ame-
liorated apoptosis in HG-stimulated podocytes. All these
findings imply that HO-1 has an important function in
cytoprotection in DM nephropathy.
In conclusion, HO-1 expression was increased in both
experimental DM glomeruli and HG-stimulated podocytes.
Moreover, inhibition of HO-1 expression further increased
albuminuria, reduced podocyte numbers in DM rats, and
accentuated podocyte apoptosis in DM glomeruli and in
podocytes exposed to HG, whereas induction of HO-1
protected HG-stimulated podocytes from apoptosis. Taken
together, these results suggest that podocyte HO-1 expression
is induced to protect podocytes against apoptosis under DM
conditions.
MATERIALS AND METHODS
Animals
All animal studies were conducted under an approved protocol.
Male Sprague–Dawley rats weighing 250–280 g were injected either
with diluent (n¼ 16, C) or with 65mg/kg streptozotocin intraper-
itoneally (n¼ 16, DM). Diabetes was confirmed by tail vein blood
glucose levels above 300mg per 100ml on the third day after
injection. After confirming DM, eight rats from each group were
treated with intraperitoneally ZnPP (50 mmol/kg/day) (Sigma-
Aldrich, Saint Louis, MO, USA) (CþZnPP, DMþZnPP) for 6
weeks. To determine whether there is a gender-specific effect of
ZnPP on DM nephropathy, the same experiments were performed
with female Sprague–Dawley rats (n¼ 24). In addition, experiments
with DM rats (n¼ 8) treated with 2U/day of insulin (Ultralente, Eli
Lilly, Indianapolis, IN, USA) were also conducted to control the
effect of streptozotocin. Rats were housed in a temperature-
controlled room and were given free access to water and standard
laboratory chow during the 6-week study period.
Body weights were checked biweekly, and the kidney weights
were measured at the time of killing. Systolic blood pressure was
measured by tail-cuff phlethysmography at 6 weeks. Serum glucose,
blood urea nitrogen and serum creatinine levels, and 24-h urinary
albumin were also measured at the time of killing. Blood glucose was
measured by a glucometer and 24-h urinary albumin excretion by
enzyme-linked immunosorbent assay (Nephrat II, Exocell,
Philadelphia, PA, USA). Blood urea nitrogen and serum creatinine
levels were determined by an automatic biochemical analyzer.
Glomerular isolation
Glomeruli were isolated by sieving. Purity of the glomerular
preparation was greater than 98% as determined by light
microscopy.
Podocyte culture
Conditionally immortalized mouse podocytes were kindly provided
by Dr Peter Mundel (Albert Einstein College of Medicine, Bronx,
NY, USA) and were cultured as described earlier.46 Briefly, frozen
podocytes were first grown under permissive conditions at 33 1C in
RPMI 1640 media containing 10% fetal bovine serum, 50U/ml
g-interferon, and 100U/ml of penicillin/streptomycin in collagen-
coated flasks, and the g-interferon was tapered down to 10U/ml in
successive passages. Cells were then trypsinized and subcultured
without g-interferon (non-permissive conditions) and allowed to
differentiate at 37 1C with media changed on alternate days.
Differentiation of podocytes grown for 10 days at 37 1C was
confirmed by the identification of synaptopodin, a podocyte
differentiation marker, by reverse transcription-PCR and western
blotting (data not shown).
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Figure 9 |A representative western blot of heme oxygenase (HO)-1 and apoptosis-related molecules in cultured podocytes
(representative of four blots). Hemin pretreatment (20 mmol) significantly induced HO-1 protein expression in cultured podocytes
exposed to normal glucose (NG) and high glucose (HG). In addition, HO-1 induction by hemin before HG stimulation significantly
attenuated the increases in Bax/Bcl-2 ratio and active fragment of caspase-3 protein expression in HG-stimulated podocytes. *Po0.005 vs
NG and HG groups, #Po0.05 vs NG group, wPo0.05 vs HG group.
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In this study, siRNA for mouse HO-1 was used to inhibit HO-1
expression. The sense and antisense sequences of mouse HO-1
siRNA were as follows: sense, 50-GGCUUUAAGCUGGUGAUGGTT-30;
and antisense, 50-CCAUCACCAGCUUAAAGCCTT-30. The concen-
trations of siRNA for this study were determined based on
preliminary experiments with three different concentrations of 10,
20 and 50 nmol siRNA. The HO-1 siRNA and a negative control
siRNA, scrambled siRNA, were transiently transfected into differ-
entiated podocytes with Lipofectamine 2000 (Invitrogen, Carlsbad,
CA, USA) for 24 h.
Transfected and nontransfected podocytes were serum-
restricted for 24 h, after which the medium was changed to RPMI
medium containing NG (5.6mmol glucose), NGþ 24.4mmol
mannitol (NGþM), NGþ 20 nmol HO-1 siRNA (Ambion,
Austin, TX, USA) (NGþ siRNA), HG (30mmol glucose), or
HGþ 20 nmol HO-1 siRNA (HGþ siRNA). To explore the effect
of HO-1 induction on HG-induced changes, podocytes were also
pretreated with 20 mmol hemin (Fluka, Buchs SG, Switzerland) for
6 h and were exposed to HG medium. After 24 h, cells were
harvested.
Western blot analysis
Sieved glomeruli and podocytes harvested from plates were lysed in
SDS sample buffer (2% SDS, 10mmol Tris-HCl, pH6.8, 10% (vol/
vol) glycerol). Lysate was centrifuged at 10,000 g for 10min at 4 1C
and the supernatant was stored at 70 1C until all rats were killed.
Protein concentrations were determined with a Bio-Rad kit (Bio-
Rad Laboratories, Hercules, CA, USA). Aliquots of 50 mg proteins
were treated with Laemmli sample buffer, then heated at 100 1C for
5min, and electrophoresed (50 mg/lane) in 8 or 12% acrylamide
denaturing SDS-polyacrylamide gel. Proteins were transferred to a
Hybond-ECL membrane (Amersham Life Science, Arlington
Heights, IL, USA) using a Hoeffer semidry blotting apparatus
(Hoeffer Instruments, San Francisco, CA, USA), and the membrane
was then incubated in blocking buffer A (1 phosphate-buffered
saline, 0.1% Tween-20, and 8% non-fat milk) for 1 h at room
temperature, followed by an overnight incubation at 4 1C in a 1:1000
dilution of monoclonal antibody to HO-1 (EMD Biosciences,
Darmstadt, Germany), polyclonal antibodies to HIF-1 (ABR-Affinity
Bioreagents, Rockford, IL, USA), active fragments of caspase-3 (Cell
Signaling, Beverly, MA, USA), Bax, Bcl-2, or b-actin (Santa Cruz
NG
Ap
op
to
tis
 (%
)
HG
20
15
5
10
0
NG+M
∗
#
#
NG+siRNA
HG+HeminHG+siRNA
NG HGNG+M NG+
siRNA
HG+
Hemin
HG+
siRNA
Figure 10 |Apoptosis assessed by Hoechst 33342 staining. There was a significant increase in apoptotic cells (arrowheads) in high
glucose (HG)-stimulated podocytes compared with normal glucose (NG) cells, and apoptosis in HG podocytes was further increased by
heme oxygenase (HO)-1 small interfering RNA (siRNA) (20 nmol). In contrast, HO-1 induction by hemin (20 mmol) before HG stimulation
significantly protected cultured podocytes against apoptosis. *Po0.05 vs NG, NGþM, and NGþ siRNA groups, #Po0.05 vs HG group.
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Biotechnology, Santa Cruz, CA, USA). The membrane was washed
three times and then incubated with a 1:1000 dilution of horseradish
peroxidase-linked goat anti-rabbit IgG (Amersham Life Science). The
washes were repeated, and the membrane was developed with
chemiluminescent agent (ECL; Amersham Life Science). The band
densities were measured using TINA image software (Raytest,
Straubenhardt, Germany), and the changes in the optical densities
relative to C glomeruli and NG cells were used for analysis.
Immunohistochemistry
Slices of kidney for immunohistochemical staining were fixed in
10% neutral-buffered formalin, processed in the standard manner,
and 4 mm sections of paraffin-embedded tissues were used. Slides
were deparaffinized, hydrated in ethyl alcohol, and washed in tap
water. Antigen retrieval was carried out in 10mmol sodium citrate
buffer for 20min using a Black and Decker vegetable steamer
(Towson, MD, USA). For HO-1, the primary monoclonal anti-HO-
1 antibody (EMD Biosciences) was diluted in 1:200 with 2% casein
in bovine serum albumin and was applied for overnight incubation
at room temperature. After washing, a secondary goat anti-rabbit
IgG (Jackson ImmunoResearch Laboratories, West Grove, PA, USA)
was added for 20min, and the slides were then washed and
incubated with a tertiary rabbit-PAP complex for 20min. Diami-
nobenzidine was added for 2min and the slides were counterstained
with hematoxylin. A semiquantitative score for measuring the
intensity of HO-1 staining within glomeruli was determined by
examining 30 glomeruli in each section and by digital image analysis
(MetaMorph version 4.6r5, Universal Imaging, Downingtown, PA,
USA) as described earlier.47 Briefly, the degree of staining was
semiquantitated on a scale of 0 to 4þ and a staining score was
obtained by multiplying the intensity of staining by the percentage
of glomeruli staining for that intensity; these numbers were then
added for each experimental animal to give the staining score.
X
ðintensity of stainingÞ
ð% of glomeruli with that intensityÞ ¼ staining score
Immunohistochemical staining for WT-1 was also performed to
determine the number of podocytes as described earlier.48 Briefly,
two adjacent 3 mm sections stained with WT-1 were observed in
pairs at a magnification of  400, and the WT-1-positive stained
nuclei present in the top but not in the bottom section were counted
and summed. Ten glomeruli in five rats from each group and 13–15
sections from the midglomerular area were examined.
Immunofluorescence
Slices of kidney for immunofluorescence staining were snap-frozen in
optimal cutting temperature solution and 4mm sections of tissues were
used. Slides were fixed in acetone for 10min at 4 1C, air-dried for
10min at room temperature, and blocked with 10% donkey serum for
20min at room temperature. For double immunofluorescence
staining, primary polyclonal antibodies to HO-1 (EMD Biosciences)
or active fragments of caspase-3 (Cell Signaling) were diluted in 1:100
with antibody diluent (DAKO, Glostrup, Denmark) and was applied
for 3 h at room temperature. After washing, Cy3 (red)-conjugated
anti-rabbit IgG antibody (Research Diagnostics, Flanders, NJ, USA)
was added for 60min. A 1:200 dilution of polyclonal anti-
synaptopodin antibody (Santa Cruz Biotechnology) was then applied,
followed by Cy2 (green)-conjugated anti-goat IgG antibody. A
semiquantitative score for measuring the intensity of active fragments
of caspase-3 was determined as aforementioned.
Measurement of HO activity
Heme oxygenase activity was determined in rat glomeruli micro-
somes by bilirubin generation.7 Microsomes, which were prepared
by centrifugation at 105,000 g for 60min at 4 1C, were resuspended
in 0.5ml of 100mmol potassium phosphate buffer (pH 7.4)
containing 2mmol MgCl2, frozen to 70 1C, and thawed three
times and sonicated on ice. The resulting supernatant (400 ml) was
added to 200 ml of reaction mixture (2mg of rat liver cytosol,
10 mmol hemin, 0.2mmol glucose-6-phosphate, 0.2U of glucose-6-
phosphate dehydrogenase, and 0.8mmol NADPH) and left at 37 1C
for 1h in the dark. The formed bilirubin was extracted with same
volume of chloroform and was calculated by the difference in absor-
bance between 464 and 530nm (extinction coefficient 40mmol/cm for
bilirubin). HO activity was expressed as picomoles of bilirubin formed
per milligram of protein per hour. The protein content of the
microsomal fraction was determined by the method of Bradford.49
TUNEL assay and Hoechst 33342 staining
In addition to the changes in the expression of apoptosis-related
molecules, apoptosis was also identified within glomeruli by TUNEL
using a commercially available kit (Chemicon International,
Temecula, CA, USA) and in cultured podocytes seeded on coverslips
by Hoechst 33342 (Molecular Probes, Eugene, OR, USA) staining.
Apoptosis was defined as TUNEL-positive cells within glomeruli and
the presence of nuclear condensation on Hoechst staining. TUNEL-
positive glomerular cells in formalin-fixed renal tissue and the
percentage of podocytes with nuclear condensation were determined
by examining at least 30 glomeruli and 300 cells per condition,
respectively, at  400 magnification.
Statistical analysis
All values are expressed as the mean±s.e.m. Statistical analysis was
performed using the statistical package SPSS for Windows Ver. 11.0
(SPSS, Chicago, IL, USA). Results were analyzed using the
Kruskal–Wallis nonparametric test for multiple comparisons.
Significant differences by the Kruskal–Wallis test were confirmed
by the Mann–Whitney U-test. P-values less than 0.05 were
considered to be statistically significant.
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